Kezar Life Sciences, Inc. (KZR) Tops Q1 EPS by 5c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q1 EPS of ($0.30), $0.05 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• RegenLab targets Nasdaq listing under ticker RGNA as revenues top $29 million
• B. Riley’s Top Biotech Picks Ahead of 3Q26 Earnings Season